Histone deacetylase (HDAC) inhibitors

Описание к видео Histone deacetylase (HDAC) inhibitors

Histone deacetylase inhibitors are a new type of myeloma treatment currently in clinical trial. Dr Charlotte Pawlyn explains how these inhibitors work and how they are likely to be given to patients.

Комментарии

Информация по комментариям в разработке